INVENTURUS KNOWLEDGE SOLUTIONS LIMITED — Investor Presentation 2025

Jul 3, 2025

July 3, 2025

BSE Limited

The Listing Department Phiroze Jeejeebhoy Towers 25[th] Floor, Dalal Street Fort, Mumbai 400 001 Maharashtra, India

National Stock Exchange of India Limited

The Listing Department Exchange Plaza, Plot No. C/1, G Block, Bandra Kurla Complex Bandra (East), Mumbai 400051 Maharashtra, India

BSE Scrip Code: 544309

NSE Symbol: IKS

Dear Sir/Ma’am,

Sub: Conference Call Presentation – “IKS - Partnership with and Investment in WWMG”

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Conference Call Presentation – “IKS - Partnership with and Investment in WWMG”.

The said presentation is also being uploaded on the website of the Company at the - https://ikshealth.com/investor relations/

Request you to take it on record and disseminate it on your website.

Thanking you.

Yours sincerely,

For Inventurus Knowledge Solutions Limited

Sameer Digitally signed by Sameer Shashikant Shashikant Chavan Date: 2025.07.03 Chavan 15:31:38 +05'30' Sameer Chavan Company Secretary and Compliance Officer Membership No. F7211

Encl: As above

IKS - Partnership with and Investment in WWMG

==> picture [76 x 29] intentionally omitted <==

==> picture [165 x 99] intentionally omitted <==

==> picture [82 x 48] intentionally omitted <==

==> picture [135 x 134] intentionally omitted <==

==> picture [86 x 51] intentionally omitted <==

==> picture [32 x 57] intentionally omitted <==

==> picture [138 x 139] intentionally omitted <==

==> picture [50 x 50] intentionally omitted <==

Disclaimer

==> picture [75 x 29] intentionally omitted <==

This presentation may include opinions and assumptions about future performance which could be considered as forward-looking statements. Forward-looking statements intrinsically cover several risks and uncertainties, which may lead to a material difference between actual results and the statements themselves. Such statements comprise the company’s current visibility on market movements, client discussions, and related factors. Inventurus Knowledge Solutions Limited does not assume an obligation to update or revise any forward-looking statements.

2

Physician groups are struggling with declining reimbursement trends

==> picture [75 x 29] intentionally omitted <==

==> picture [693 x 293] intentionally omitted <==

----- Start of picture text -----

RISING COST, DECLINING THE IMPACT IS ACROSS ALL
FFS REIMBURSEMENT SPECIALTIES
Anesthesiology, Cardiac Surgery,
MEDICARE Colorectal Surgery, Diagnostic testing
PHYSICIAN PAY 9.8% -3% to - 4% facilities, Emergency medicine,
Interventional radiology
GROWTH [1]
-2% to -3% Nuclear Medicine, Optometry, Oral Surgery,
Pathology, Physical & Occupational Therapy
PRACTICE
OPERATING COSTS 54% -1% to -2% Radiation Oncology, Family Medicine & Internal
INCREASE [2] Medicine, Hemato-Oncology
REIMBURSEMENT V. OPERATING EXPENSE ANNUALIZED IMPACT ON REIMBURSEMENT
GROWTH (2001 - 2024) ACROSS SPECIALTIES [3]
1. CMS DATA’ 3. HFMA - Medicare’s 2025 payment updates: Why hospitals
2. AMA s MEDICARE ECONOMIC INDEX (MEI) THAT
and physicians think the methodologies are fawed
MEASURES PRACTICE COST INFLATION 3
----- End of picture text -----

With current solutions not delivering the right outcomes, the market is ready for a solution that works

==> picture [75 x 29] intentionally omitted <==

==> picture [66 x 65] intentionally omitted <==

==> picture [66 x 65] intentionally omitted <==

==> picture [66 x 65] intentionally omitted <==

PHYSICIAN AGGREGATION MODELS HAVEN’T DELIVERED

VALUE-BASED CARE IS STRUGGLING

HEALTH IT COSTS WAY MORE THAN IT DELIVERS

% of Physicians employed by hospitals 69% / health systems or other corporate entities (2021)[1]

Impact of investment for physician aggregation on key indicators[2]

==> picture [37 x 80] intentionally omitted <==

Cost of Care

Utilization

Quality

Operating cost

1. ACQUISITIONS OF PHYSICIAN PRACTICES AND PHYSICIAN EMPLOYMENT, PHYSICIAN ADVOCACY INSTITUTE, 2021 2. EVALUATING TRENDS IN PRIVATE EQUITY OWNERSHIP AND IMPACTS ON HEALTH OUTCOMES, COSTS, AND QUALITY: SYSTEMATIC REVIEW, BMJ 2023

IMPACT ON REIMBURSEMENT IN MEDICARE ADVANTAGE 12 TO (MA) 18% WITH MOVE TO V.28 ACROSS 3 YEARS[3]

MA-FOCUSED FIRMS FILING BANKRUPTCY OR EXITING MA IN THE LAST 2 YEARS[4]

==> picture [54 x 25] intentionally omitted <==

==> picture [45 x 23] intentionally omitted <==

==> picture [66 x 16] intentionally omitted <==

==> picture [54 x 28] intentionally omitted <==

==> picture [44 x 25] intentionally omitted <==

==> picture [238 x 24] intentionally omitted <==

----- Start of picture text -----

3. IKS ANALYSIS
4. INDUSTRY NEWS
----- End of picture text -----

Doesn’t have the desired impact 71% Executives haven’t seen cost reduction after deploying technology[5]

Restricted by fragmented tech Of Physicians feel they get critical or <50% timely information on their patients to make the right decisions[6] 5. CIRRUS MD SURVEY 6. HEALTHCARE FRAGMENTATION IS COSTING YOU: HERE'S HOW TO FIX IT

4

Consolidation led by PE groups and hospitals hasn’t delivered the desired outcomes

==> picture [75 x 29] intentionally omitted <==

Often the approach has been focused on driving growth while overlooking holistic care, leading to continued high utilization and costs

Mostly focused on low-hanging fruit of better payer contracts or improved supplier / vendor costs

Lack of focus on true care transformation that can help lower cost, expand access and improve quality Limited clinician’s ability or agency and curtailed their earning potential

==> picture [250 x 264] intentionally omitted <==

5

==> picture [362 x 405] intentionally omitted <==

==> picture [76 x 29] intentionally omitted <==

IKS’ approach is different

6

IKS is the right partner for Physician groups in driving better clinical, financial and operational outcomes

==> picture [75 x 29] intentionally omitted <==

==> picture [686 x 302] intentionally omitted <==

----- Start of picture text -----

REDUCTION IN OVERALL COST OF OPERATIONS
With a pragmatic combination of technology and globalized human capital that delivers significant
operating synergies and compounding value
ENABLING BETTER QUALITY OF CARE IMPROVED
With clinically rigorously tested solutions that improve capture of quality of care metrics reduce FINANCIAL
variation in care and drive more proactive chronic condition identification
OUTCOMES
With more efficient
FACILITATING EXPANDED CAPACITY & ACCESS operations, expanded
By eliminating administrative distractions; giving clinicians and clinic teams the tools and time to focus access and lower
on direct patient care total cost of care
REDUCING COST OF CARE
Through proactive management of chronic conditions with evidence-based disease management,
combined with risk stratification based on clinical disease progression
----- End of picture text -----

7

This approach delivers tremendous value, the whole delivering more than the sum of its parts

==> picture [75 x 29] intentionally omitted <==

==> picture [687 x 298] intentionally omitted <==

----- Start of picture text -----

Value from components of When combined create While also delivering additive
platform… accretive synergies… compounding effect
Better
revenue
capture
8.9% 11.1% 11.7%
Improved
Reduced clinician
operating efficiency -
costs more visits
2.2% 0.6%
Accretive efficiency gains Additive compounding
through improving parts of effect as a result of
All numbers calculated as care delivery through IKS improved outcomes
----- End of picture text -----

All numbers calculated as net EBITDA gain as % of revenue

88

We are now making the leap from being a platform provider to a transformation partner

==> picture [75 x 29] intentionally omitted <==

==> picture [107 x 102] intentionally omitted <==

----- Start of picture text -----

IKS 2.0
----- End of picture text -----

Building the platform

IKS is a high cash generating business With extremely positive unit economics and low SG&A costs

With a capital-light model Giving us the liberty to find different ways to deploy cash

==> picture [104 x 86] intentionally omitted <==

----- Start of picture text -----

IKS 3.0
----- End of picture text -----

Becoming a Transformation partner

WHY WE NEED EVOLUTION?

==> picture [32 x 83] intentionally omitted <==

==> picture [32 x 35] intentionally omitted <==

Still perceived as an enabling solution, where features can be commoditized

Majority of burden to recognize ROI from the platform is still incumbent on the client

EHR vendors trying to exercise their leverage to prevent us from creating value

Limited debt and strong fundamentals

Gives us the ability to conservatively leverage our balance sheet and drive deeper alignment with customers

Demand in the market to create aligned incentives

Significantly increases our stickiness with customers and a platform install creates a moat that is harder to replicate

Offering:

A comprehensive solution that brings capital, capacity & capabilities and takes ownership of outcomes from organizational transformation

Differentiator / Moat:

Fully invested in client’s strategic transformation

9

Engaging in 3 models of combining our capabilities with our capital to create deeper alignment with our customers

==> picture [75 x 29] intentionally omitted <==

LAUNCHING A JV TO DRIVE GROWTH IN VERTICAL MARKETS

UNDERWRITING PERFORMANCE OUTCOMES

INVESTING IN MEDICAL GROUP GROWTH

Level of capital requirement* LOW TO MODERATE

Level of capital requirement* MODERATE

Level of capital requirement* HIGHER

*For similar deal size, scope and revenue potential

10

An investment in Western Washington Medical Group (WWMG) presents an opportunity to manifest IKS 3.0

==> picture [75 x 29] intentionally omitted <==

INVESTING IN MEDICAL GROUP GROWTH

WWMG as a multi-specialty group; presents an opportunity to invest in enabling Medical Group growth through the MSO

Level of capital requirement*

This would create a “proof-point” for the IKS 3.0 model where IKS can enable and participate in medical group growth

HIGHER

Jointly, the two teams can partner to enable WWMG to grow it’s physician base and to drive success in fee-for-service and value-based care

11

Western Washington Medical Group at-a-glance

==> picture [75 x 29] intentionally omitted <==

==> picture [113 x 68] intentionally omitted <==

==> picture [45 x 45] intentionally omitted <==

==> picture [45 x 45] intentionally omitted <==

==> picture [45 x 44] intentionally omitted <==

==> picture [548 x 254] intentionally omitted <==

----- Start of picture text -----

$91M 30+ 31
Primary Care Providers
Annual patient revenue Years of Experience
(Including APPs)
90+ 20 40%
Clinicians Specialties Owned by physicians
49 6
Physicians are shareholders; Primary Care Locations $18.4M
reflective of a strong physician
owned, physician-led culture Pre-money Valuation of MSO
25
Total Medical Offices
----- End of picture text -----

12

Through proven revenue enhancement solutions, cost reductions, clinician additions, and new VBC business, MSO EBITDA should increase substantially

==> picture [75 x 29] intentionally omitted <==

==> picture [67 x 67] intentionally omitted <==

==> picture [67 x 67] intentionally omitted <==

==> picture [67 x 67] intentionally omitted <==

==> picture [67 x 67] intentionally omitted <==

Revenue Upsides Cost Reduction Adding Clinicians Value Based Care Reduce leakages across the CBO solution reduces revenue IKS platform reduces the IKS platform helps the group take Revenue Cycle - 2% upside cycle costs - 30% to 40% administrative burden on on full-risk contracts, adding 124 clinicians, reduces clinician patients per PCP. Referral Management and Patient Virtual Clinical Assistant solution burnout, increases clinician Access solutions drive 1.5% to 2% reduces MA costs - 20% satisfaction, and reduces Increase RAF scores by 8%. more visits operating costs, allowing the Medical records cost reduction - medical group to hire better and Reduce Medical Cost Ratio (MCR) Clinical documentation increases 10% retain more clinicians. by 6%. productivity by 10% Virtual Clinical Assistant solution increases productivity by 1%

13

Transaction Structure

37.4% Revenue Share

==> picture [75 x 29] intentionally omitted <==

==> picture [552 x 336] intentionally omitted <==

----- Start of picture text -----

100%
Shareholding
Shareholders/
Collections
Providers
52%
62.6% Shareholding
Revenue Share
MSO
48% shareholding
IKS will capture 48% of the value
from EBITDA improvement in the
MSO
----- End of picture text -----

14

Transaction Structure - Genesis of the MSO

==> picture [75 x 29] intentionally omitted <==

Due to Corporate Practice of Medicine regulations in Washington, IKS cannot directly invest in WWMG

A Managed Services Organization (MSO) is being established to handle all non-clinical operations of WWMG

WWMG will split into a dual structure Professional Corporation (the Practice) for clinical staff and the MSO for non-clinical aspects.

The Practice will pay the MSO a management fee equal to 62.6% of collections for non-clinical services, retaining 37.4% for provider compensation

IKS will initially invest $17M into the MSO.The initial investment proceeds will be a low-interest, long-term loan from the MSO to WWMG to fund organic and inorganic growth in physicians

The MSO will oversee all non-clinical operations of WWMG, including revenue cycle management, clinical documentation, HR, IT, and finance. The Clinical operations will continue to reside within a separate Professional Corporation (the “Practice”), allowing for a clear separation of clinical and administrative functions.

15

This is a strategic investment to elevate our market position, deepen our influence and drive future growth

==> picture [75 x 29] intentionally omitted <==

Positions IKS to lead strategic transformation amid evolving healthcare market dynamics

Advances IKS up the value chain, differentiating from commoditized point solution providers; and creates a path for unlimited capital light growth

Enables the creation of a sustainable model for Physician aggregation that delivers the quadruple aim

Leverages IKS’s strong fundamentals to deliver two pools of economic value

Creates a moat and sustained stickiness for our core Care Enablement Platform business model

16

IKS is uniquely positioned to make a difference in the market this investment in WWMG is a great starting point

==> picture [75 x 29] intentionally omitted <==

1

The large, $1.5Tn physician market presents a significant untapped efficiency potential

2

Consolidation, led by Private Equity or Hospitals, has not meaningfully impacted cost of care, quality of care or margins for physician groups

3

IKS, with our proven Care Enablement Platform with broad capabilities, is uniquely positioned to unlock operational and financial synergies

4

This investment in the MSO creates 2 pools of economics for IKS - enables IKS to participate in the long-term value created in the medical group and the MSO; economics from the IKS platform enabling the MSO and WWMG

17

Solid track record of Return on our Strategic Investments so far

==> picture [75 x 29] intentionally omitted <==

Strategic Investments	Status	Investment	Sale price/ Current Value	Total ROE	Investment CAGR
Lightbeam Health	Invested	100,000	1,300,000	1200%	33%
Sift Medical Data Inc	Sold	2,000,000	4,097,463	105%	94%
Abridge AI Inc	Invested	1,249,998	22,686,240	1715%	325%
Abridge AI Inc	Sold	3,750,002	14,092,144	276%	255%
The current valuation of	securities is	an estimate derived from recent fundraising valuations

==> picture [139 x 140] intentionally omitted <==

Join the Movement Grow, Scale, Thrive

==> picture [720 x 63] intentionally omitted <==